Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Category Archives: Patient safety and risk
Gastrointestinal system: association between proton pump inhibitors and chronic kidney disease (Feb-16)
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Variations in Prescribing Safety in UK General Practices – Room for Improvement (Dec-15)
Authorised users need to be logged in to read this content.
NPC Archive Item: Electronic prescribing systems significantly reduce prescribing error rates
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 23 April 2012 A study has shown that two commercial electronic prescribing systems were associated with a statistically significant reduction in total prescribing error rates (66.1%, 57.5% and 60.5% […]
NPC Archive Item: Study highlights the social complexity of GP repeat prescribing
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 5 May 2011 An ethnographic case study of four GP practices found that repeat prescribing was a complex, technology-supported social practice, requiring collaboration between administrative staff and clinicians, with […]
NPC Archive Item: Improving medication safety for people in care homes
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 13 September 2011 Summary In July 2011 the learning report from the Health Foundation project ‘Making care safer – Improving medication safety for people in care homes: thoughts and […]
NPC Archive Item: FDA restricts the use of simvastatin 80 mg because of an increased risk of myopathy
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 24 August 2011 Following a review of safety data, the US FDA has restricted the use of simvastatin▼* 80 mg to reduce the risk of muscle damage (myopathy). The […]
NPC Archive Item: FDA concludes that A2RAs don’t increase the risk of cancer
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20 July 2011 An FDA meta-analysis of 31 randomised controlled trials found that treatment with an angiotensin-2 receptor antagonist (A2RA) does not increase the risk of cancer. Level of […]
NPC Archive Item: An improved organisational culture can support performance in healthcare
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 5 July 2011 Summary Organisational culture matters when introducing change and in achieving high performance in healthcare. Some of the reasons why organisations may struggle to deliver change are: […]
NPC Archive Item: Olmesartan reduces disease oriented outcomes but may have potential cardiovascular safety concerns
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 28th March 2011 The ROADMAP trial found olmesartan delayed the onset of microalbuminuria in patients with type 2 diabetes and normoalbuminuria. While this disease-oriented outcome (DOO) suggested a potential benefit […]